Pureland Global Venture

Pureland Global Venture (“Pureland”) is a global healthcare venture capital firm. As Enterprise Singapore’s designated co-investment partner, our mission is to deliver medical solutions and savings to over 100 million people around the world. At Pureland, we look for visionary entrepreneurs who combine integrity, intelligence, and passion to address pressing healthcare challenges innovatively and ethically. Focused on early to growth-stage investments, Pureland specializes in sectors including medical devices, digital health, healthcare services, and AI-empowered solutions. We have particular interests in areas such as oncology, ophthalmology, brain health, orthopedics, cardiology, and other chronic disease management. Our globally diversified portfolio comprises 60% allocation in the U.S. and the remaining 40% distributed across Singapore, India, and the EU. Our engagement extends beyond financial investment. We provide robust post-investment support, focusing on strategy development, distribution, cross-border expansion, and manufacturing/OEM partnerships. We strive to establish an ecosystem that fosters collaboration among start-ups, government bodies, clinical, investment, and commercial partners. This approach ensures that portfolio companies receive comprehensive support, aiding in their growth and impactful contribution to the healthcare sector.

Website

https://www.purelandgroup.co/purelandventure

External link for Pureland Global Venture

Industry

Venture Capital and Private Equity Principals

Company size

11-50 employees

Headquarters

Singapore

Type

Privately Held

Specialties

Impact Investing, Venture Capital, Private Investment, Healthcare, and Medical Device